Skip to content

MGD-3 Fetal Ultrasonic Monitor

by Kt Medical, Inc. 510(k)

Active United States

510(k) K800095

Overview

The MGD-3 is a Monitor, Ultrasonic, Fetal, designed to evaluate fetal heart rate and uterine contractions during pregnancy. This Class II device employs ultrasonic technology to provide real-time monitoring of fetal well-being, supporting clinical assessments in obstetric settings. Its primary function aligns with obstetrics/gynecology applications, where continuous or intermittent fetal surveillance is critical. The device adheres to FDA-recognized standards for fetal monitoring, ensuring compliance with regulatory requirements for diagnostic accuracy and safety.

The MGD-3 is supplied as a reusable medical device, intended for use in clinical environments such as hospitals, birthing centers, or obstetric clinics. It operates under non-sterile conditions for routine monitoring but may require cleaning and maintenance per manufacturer guidelines. The device is classified under FDA regulation 884.2660 and holds a Traditional 510(k) clearance (K800095) for obstetrics/gynecology applications. No specific MRI safety classification or single-use designation is noted in the regulatory records.

AI-generated from registry data, 1 Oct 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK800095 Date11 Feb 1980ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

Full name
Mgd-3
510(k) Number
FDA Product Code
KNG
Device Class
Class II
Regulation
21 CFR Part 884.2660
Advisory Committee
Obstetrics/Gynecology
FDA Decision
SESE Substantially Equivalent

Other devices from Kt Medical, Inc.

See all devices from Kt Medical, Inc. →

Questions

  • What is the MGD-3 fetal monitor used for?

    The MGD-3 is designed to evaluate fetal heart rate and uterine contractions during pregnancy. This real-time monitoring supports clinical assessments in obstetrics/gynecology, helping healthcare providers assess fetal well-being in settings like hospitals, birthing centers, or obstetric clinics. Its ultrasonic technology ensures accurate diagnostic evaluation as part of routine fetal surveillance.

  • Is the MGD-3 a single-use or reusable device?

    The MGD-3 is a reusable medical device. It is intended for use in clinical environments where proper cleaning and maintenance per manufacturer guidelines are required. This design allows for repeated use across multiple patients, provided the device remains functional and adheres to hygiene protocols.

  • What regulatory approval does the MGD-3 hold?

    The MGD-3 holds a Traditional 510(k) clearance (K800095) from the FDA under regulation 884.2660. This clearance confirms its substantial equivalence to a predicate device and compliance with FDA-recognized standards for fetal monitoring in obstetrics/gynecology applications. The device is classified as Class II, reflecting its role in diagnostic procedures.

  • How should the MGD-3 be stored?

    While the MGD-3 is intended for non-sterile use during routine monitoring, proper storage is critical to maintain its functionality and hygiene. The device should be stored in a clean, dry environment, protected from physical damage or contamination. Follow the manufacturer’s guidelines for cleaning, maintenance, and storage to ensure optimal performance and longevity.

  • Does the MGD-3 have any specific MRI safety classification?

    The regulatory records for the MGD-3 do not specify an MRI safety classification. If MRI compatibility is required in your clinical setting, verify with the manufacturer or consult their technical documentation to ensure safe use in proximity to MRI equipment. Always follow facility protocols for devices without explicit MRI clearance.